BACKGROUND: Since the publication of the first genome screen for prostate cancer (CaP) 5 years ago, over a dozen linkage studies have appeared. Most attention has been directed to chromosome 1, where two separate regions have been identified as harboring a prostate cancer susceptibility locus: HPC1 in the 1q24-25 interval and PCaP in the 1q42.2-43 interval. Linkage analysis of chromosome 16 has also provided evidence of harboring two loci predisposing to CaP. METHODS: We report on a replication linkage study of chromosomes 1 and 16 in 45 new and 4 expanded multiplex CaP families. Multipoint Z-scores were obtained for 30 highly polymorphic short-sequence tandem repeat markers spanning chromosome 1, and 22 markers spanning chromosome 16. RESULTS: The replication sample gave no evidence for a CaP susceptibility locus in the 1q24-25 interval and equivocal evidence for such a locus at 1q42.2-43. With respect to chromosome 16, positive Z-scores were obtained over a contiguous interval covering the entire p arm and the proximal half of the q arm. CONCLUSIONS: The linkage analysis of our replication sample does not support the existence of HPC1, and the evidence for the existence of PCaP remains equivocal. Evidence of a susceptibility locus on 16p remains strong, but the evidence for a susceptibility locus on 16q is weakened. Copyright 2000 Wiley-Liss, Inc.
BACKGROUND: Since the publication of the first genome screen for prostate cancer (CaP) 5 years ago, over a dozen linkage studies have appeared. Most attention has been directed to chromosome 1, where two separate regions have been identified as harboring a prostate cancer susceptibility locus: HPC1 in the 1q24-25 interval and PCaP in the 1q42.2-43 interval. Linkage analysis of chromosome 16 has also provided evidence of harboring two loci predisposing to CaP. METHODS: We report on a replication linkage study of chromosomes 1 and 16 in 45 new and 4 expanded multiplex CaP families. Multipoint Z-scores were obtained for 30 highly polymorphic short-sequence tandem repeat markers spanning chromosome 1, and 22 markers spanning chromosome 16. RESULTS: The replication sample gave no evidence for a CaP susceptibility locus in the 1q24-25 interval and equivocal evidence for such a locus at 1q42.2-43. With respect to chromosome 16, positive Z-scores were obtained over a contiguous interval covering the entire p arm and the proximal half of the q arm. CONCLUSIONS: The linkage analysis of our replication sample does not support the existence of HPC1, and the evidence for the existence of PCaP remains equivocal. Evidence of a susceptibility locus on 16p remains strong, but the evidence for a susceptibility locus on 16q is weakened. Copyright 2000 Wiley-Liss, Inc.
Authors: Ethan M Lange; Jennifer L Beebe-Dimmer; Anna M Ray; Kimberly A Zuhlke; Jaclyn Ellis; Yunfei Wang; Sarah Walters; Kathleen A Cooney Journal: Prostate Date: 2009-03-01 Impact factor: 4.104
Authors: Prodipto Pal; Huifeng Xi; Ritesh Kaushal; Guangyun Sun; Carol H Jin; Li Jin; Brian K Suarez; William J Catalona; Ranjan Deka Journal: Hum Genet Date: 2006-06-17 Impact factor: 4.132
Authors: Paul T Jubinsky; Mary K Short; George Mutema; Randal E Morris; Georgianne M Ciraolo; Maomi Li Journal: J Mol Histol Date: 2005-02 Impact factor: 2.611
Authors: Alison P Klein; Mariza de Andrade; Ralph H Hruban; Melissa Bondy; Ann G Schwartz; Steven Gallinger; Henry T Lynch; Sapna Syngal; Kari G Rabe; Michael G Goggins; Gloria M Petersen Journal: Cancer Biol Ther Date: 2007-03-15 Impact factor: 4.742
Authors: Phillippa J Neville; David V Conti; Pamela L Paris; Howard Levin; William J Catalona; Brian K Suarez; John S Witte; Graham Casey Journal: Neoplasia Date: 2002 Sep-Oct Impact factor: 5.715